MedPath

Efficacy and safety evaluation study of add-on therapy of hyaluronic acid complex to anticholinergics in overactive bladder male patients

Not Applicable
Completed
Conditions
Diseases of the genitourinary system
Registration Number
KCT0004168
Lead Sponsor
Koera University Guro Hospital
Brief Summary

A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
50
Inclusion Criteria

? Male patient who visited urology department with overactive bladder according to ICS criteria or
male patients who visited urology department due to lower urinary tract symptoms and patients with overactive bladder according to ICS criteria despite of a-blocker treatment
? Patients with an OABSS total score = 3 and No. 3 (urgent urine) = 2 score
? Those who have voluntarily agreed in writing to participate in this study

Exclusion Criteria

? Patient whose bacterium is cultured by urinalysis
? Patients with urethral or bladder neck stenosis
? Patients with urinary stones
? cancer in urinary tract
? Patients with urethral diverticulum
? Patients with Tuberculosis
? Patients with a history of pelvic radiation therapy
? Those who can not follow up until 3 months after treatment

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean OABSS score before and after treatment in both groups
Secondary Outcome Measures
NameTimeMethod
Difference between the two groups in terms of mean IPSS scores;Difference between the two groups in terms of mean IPSS subscores(storage symptoms, voiding symptoms, and QOL(quality of life));Difference between the two groups in terms of mean OABSS subscores (Urgency, Daytime Frequency, Night-Time Frequency, and Urgency Incontinence);safety evaluation: side effects, laboratory test results
© Copyright 2025. All Rights Reserved by MedPath